Hurdles in therapy with regulatory T cells

P Trzonkowski, R Bacchetta, M Battaglia… - Science translational …, 2015 - science.org
Improper activation of the immune system contributes to a variety of clinical conditions,
including autoimmune and allergic diseases as well as solid organ and bone marrow …

Improving the efficacy of regulatory T cell therapy

P Baeten, L Van Zeebroeck, M Kleinewietfeld… - Clinical reviews in …, 2022 - Springer
Autoimmunity is caused by an unbalanced immune system, giving rise to a variety of organ-
specific to system disorders. Patients with autoimmune diseases are commonly treated with …

Therapy of type 1 diabetes with CD4+ CD25highCD127-regulatory T cells prolongs survival of pancreatic islets—Results of one year follow-up

N Marek-Trzonkowska, M Myśliwiec, A Dobyszuk… - Clinical …, 2014 - Elsevier
It is hypothesized that CD4+ CD25+ FoxP3+ regulatory T cells (Tregs) can prevent
destruction of pancreatic islets protecting from type 1 diabetes (DM1). Here we present …

Administration of CD4+CD25highCD127 Regulatory T Cells Preserves β-Cell Function in Type 1 Diabetes in Children

N Marek-Trzonkowska, MŁ Myśliwiec… - Diabetes …, 2012 - Am Diabetes Assoc
OBJECTIVE Type 1 diabetes is a condition in which pancreatic islets are destroyed by self-
reactive T cells. The process is facilitated by deficits in the number and suppressive activity …

Mesenchymal stem cells transfer mitochondria to allogeneic Tregs in an HLA-dependent manner improving their immunosuppressive activity

K Piekarska, Z Urban-Wójciuk, M Kurkowiak… - Nature …, 2022 - nature.com
Cell-based immunotherapies can provide safe and effective treatments for various disorders
including autoimmunity, cancer, and excessive proinflammatory events in sepsis or viral …

Adoptive transfer of allogeneic regulatory T cells into patients with chronic graft-versus-host disease

A Theil, S Tuve, U Oelschlägel, A Maiwald, D Döhler… - Cytotherapy, 2015 - Elsevier
Background aims Mouse models indicate that adoptive transfer of regulatory T cells (Treg)
may suppress graft-versus-host-disease (GvHD) while preserving graft-versus-leukemia …

[HTML][HTML] Adoptive therapy with amyloid-β specific regulatory T cells alleviates Alzheimer's disease

HJ Yang, SY Park, H Baek, C Lee, G Chung, X Liu… - Theranostics, 2022 - ncbi.nlm.nih.gov
Rationale: Neuroinflammation is a primary feature of Alzheimer's disease (AD), for which an
increasing number of drugs have been specifically developed. The present study aimed to …

[HTML][HTML] Successful expansion of functional and stable regulatory T cells for immunotherapy in liver transplantation

N Safinia, T Vaikunthanathan, H Fraser, S Thirkell… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Strategies to prevent organ transplant rejection whilst minimizing long-term
immunosuppression are currently under intense investigation with regulatory T cells (Tregs) …

Helios is a marker, not a driver, of human Treg stability

AJ Lam, P Uday, JK Gillies… - European Journal of …, 2022 - Wiley Online Library
Treg therapy holds promise as a potentially curative approach to establish immune
tolerance in transplantation and autoimmune disease. An outstanding question is whether …

[HTML][HTML] Optimized CRISPR-mediated gene knockin reveals FOXP3-independent maintenance of human Treg identity

AJ Lam, DTS Lin, JK Gillies, P Uday, AM Pesenacker… - Cell Reports, 2021 - cell.com
Regulatory T cell (Treg) therapy is a promising curative approach for a variety of immune-
mediated conditions. CRISPR-based genome editing allows precise insertion of transgenes …